Berlin, 15.12.2020 - M1 Kliniken AG and HAEMATO AG today signed a contract for the acquisition of all shares in M1 Aesthetics GmbH by HAEMATO AG. M1 Kliniken AG will contribute M1 Aesthetics GmbH to HAEMATO AG within the scope of a capital increase through contribution in kind. For this purpose, the Management Board of HAEMATO AG decided today with [ … ]

Berlin, 15.12.2020 - M1 Kliniken AG and HAEMATO AG today signed a contract for the acquisition of all shares in M1 Aesthetics GmbH by HAEMATO AG. M1 Kliniken AG will contribute M1 Aesthetics GmbH to HAEMATO AG within the scope of a capital increase through contribution in kind. For this purpose, the Management Board of HAEMATO AG decided today with [ … ]

Schönefeld, 30.11.2020 - The supervisory board of HAEMATO AG has appointed Mr. Patrick Brenske to the board of directors of HAEMATO AG at its meeting today. With immediate effect Mr. Patrick Brenske will take over the responsibility for the product business as well as for purchasing and sales. Until 2015 Mr. Brenske worked for the HAEMATO Group f [ … ]

November 23, 2020The sales of HAEMATO AG increased in the first nine months of 2020 by 23.8 % compared to the same period of the previous year to 175.6 million EUR. HAEMATO AG, Berlin (ISIN: DE000A289VV1), achieved IFRS group sales of EUR 59.8 million in the third quarter of 2020 (previous year: EUR 47.8 million). For the observed period from Janu [ … ]

First Berlin Equity Research hat ein Research Update zu HAEMATO AG (ISIN: DE000A289VV1) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und bestätigt sein Kursziel von EUR 48,00. Zusammenfassung: Der Sechsmonatsbericht zeigte die Auswirkungen des verbesserten Produktportfolios. Der Umsatz im ersten Halbjahr und [ … ]